| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $365K | -10.1% | -9.2% |
| Cost of Revenue | $19.5M | +37.2% | -1.9% |
| R&D Expense | $15.0M | -25.7% | -37.5% |
| SG&A Expense | $28.0M | -12.2% | -17.7% |
| Operating Income | -$66.2M | +5.4% | +19.0% |
| Pre-tax Income | -$64.4M | +4.3% | +13.5% |
| Income Tax | $0 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $128.8M | -21.3% | -25.3% |
| Short-term Investments | $264.8M | -13.4% | -44.7% |
| Current Assets | $459.0M | -13.9% | -35.6% |
| Total Assets | $853.5M | -5.0% | -16.0% |
| Current Liabilities | $160.0M | +1.6% | +1.3% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$187.7M | — | — |
| Capital Expenditures | $155.9M | — | — |
| Investing Cash Flow | $29.9M | — | — |
| Financing Cash Flow | $105.7M | — | — |
| Free Cash Flow | -$343.6M | — | — |
| +100.0% |
| -100.0% |
| Net Income | -$64.4M | +4.3% | +13.6% |
| EPS (Basic) | -$1.09 | +25.9% | +59.0% |
| EPS (Diluted) | -$1.09 | +25.9% | +59.0% |
| $627.6M |
| -1.2% |
| -3.5% |
| Stockholders' Equity | $225.9M | -14.2% | -38.3% |